Target intelligence / Profile preview

RAB5C antisense RNA 1 (RAB5C-AS1)

Target: RAB5C-AS1
Molecular classification: Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)

Overview

RAB5C antisense RNA 1 (RAB5C-AS1) is a long non-coding RNA (lncRNA), classified as a natural antisense transcript, meaning it is transcribed from the DNA strand opposite the RAB5C gene[1][2]. Antisense lncRNAs, including RAB5C-AS1, can regulate the expression of overlapping or nearby genes via chromatin modification, transcriptional interference, or direct RNA-RNA interactions, but the specific functional impact of RAB5C-AS1 remains uncharacterized in the scientific literature[3][1]. There is currently no evidence supporting a direct disease role, biomarker status, or druggability for this lncRNA. RAB5C-AS1 is recognized in major genomic databases (HGNC:55289, NCBI Gene:105371781, Ensembl:ENSG00000267658)[1][2]. Its biological significance, if any, may lie in the regulation of RAB5C or related vesicular trafficking pathways, but this has not been directly demonstrated for RAB5C-AS1.

Other names: RAB5C-AS1

Mechanism of action

Not applicable. No therapeutic agents are currently known to interact specifically with RAB5C-AS1.

Biological functions

Regulation of gene expression (likely in cis, affecting RAB5C or neighboring genes)May modify chromatin state or transcript stability, by mechanisms common to other lncRNA antisense transcripts

Disease associations

No direct disease associations have been robustly characterized or validated for RAB5C-AS1 as of current searchable resources. Similar antisense lncRNAs can play roles in cancer, drug resistance, or cellular transformation, but for RAB5C-AS1 specifically, such roles are not established.

Beyond the preview

Go deeper on RAB5C antisense RNA 1 (RAB5C-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB5C antisense RNA 1 (RAB5C-AS1).

Explore the full profile